| 产品详情 |
| Edit |   |
|---|
| Antigenic Specificity | CD20 |
|---|
| Clone | monoclonal |
|---|
| Host Species | Mouse |
|---|
| Reactive Species | human |
|---|
| Isotype | IgG1 - kappa |
|---|
| Format | unconjugated |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | ELISA, IP, FC, FuncS, IF, Neut |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | Anti-Human CD20 Therapeutic Antibody (Zevalin). Recombinant monoclonal antibody to Human CD20. Ibritumomab tiuxetan, sold under the trade name Zevalin, is a monoclonal antibody radioimmunotherapy treatment for relapsed or refractory, low grade or transformed B cell non-Hodgkin's lymphoma, a lymphoproliferative disorder and thus affects the lymphatic system. The drug uses the monoclonal mouse IgG1 antibody ibritumomab (pronounced as ) in conjunction with the chelator tiuxetan, to which a radioactive isotope (either yttrium-90 or indium-111) is added. Tiuxetan is a modified version of DTPA whose carbon backbone contains an isothiocyanatobenzyl and a methyl groupSuitable for use in ELISA, western blot, immunohistochemistry, flow cytometry, immunoaffinity purification and most other immunological methods. ELISA, IP, FC, FuncS, IF, Neut and most other immunological methods. |
|---|
| Immunogen | Human lymphoblastoid cell line SB |
|---|
| Other Names | Ibritumomab;zevalin;174722-31-7;Zevalin;Ibritumomab ;DB00078MS4A1;membrane-spanning 4-domains, subfamily A, member 1;CD20;B-lymphocyte antigen CD20;B1;Bp35;MS4A2;CD20 antigen;CD20 receptor;leukocyte surface antigen Leu-16;B-lymphocyte cell-surface antigen |
|---|
| Gene, Accession # | Gene ID: 931 |
|---|
| Catalog # | TAB-001 |
|---|
| Price | |
|---|
| Order / More Info | CD20 Antibody from CREATIVE BIOLABS |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|